10 February 2026

 11:00 am - 1:00 pm

 Hosted by

Overview

11:00 - 11:25 | Automation in Medical Laboratories: Transforming Efficiency, Quality, and Patient Care | Prof. Tomris Ozben

11:25 - 11:50 | Clinical Usefulness and Pitfalls of Serum Oncomarkers Testing | Dr. David Starostka

11:50 - 12:15 | Case-Based Challenges in Primary Aldrosteronism Testing | Prof. Houqing Zhou

12:15 - 12:40 | Innovations in Laboratory: Clinical Excellence with Snibe Diagnostic Systems | Dr. Sabina Ibrahimova

12:40 - 13:00 | Q & A

This session explores transformative advances in laboratory medicine, highlighting automation’s role in enhancing efficiency, quality, and patient care. Experts address clinical nuances in serum oncomarkers, primary aldosteronism, congenital adrenal hyperplasia, and celiac disease diagnostics. Innovations in diagnostic systems (Snibe) and total laboratory automation (TLA) implementation are showcased alongside case-based insights. Sessions emphasizes scaling quality in high-volume networks and mastering large-scale lab operations exceeding 20,000 tests daily. Discussions span cardiovascular and endocrine disorders, underlining the critical link between cutting-edge technology and precision diagnostics in modern healthcare.

Learning objectives

• Understand how automation enhances laboratory efficiency, quality, and patient outcomes.
• Evaluate clinical benefits and limitations of serum oncomarker testing.
• Identify challenges and best practices in diagnosing primary aldosteronism and congenital adrenal hyperplasia.
• Recognize the value of integrated diagnostic platforms like Snibe TLA in clinical workflows.
• Learn strategies for scaling quality and managing high-throughput laboratory

 10 February 2026

 2:00 - 4:00 pm

 Hosted by

Overview

14:00 - 14:25 | Congenital Adrenal Hyperplasia - Chemistry of Dilemma | Dr. Alap Christy

14:25 - 14:50 | Clinical Significance of DGP Along with tTG for Celiac Disease Diagnosis | Prof. Dr. Rizwan Uppal

14:50 - 15:15 | From Core Lab to Referral Hub: Our Experience Implementing Snibe T8 TLA | Dr. Mohammad AlZubaidi

15:15 - 15:40 | Beyond Traditional Biomarkers: H-FABP and hs-CRP in Cardiovascular Risk Assessment | Dr. Hasaf Kolakkadan

15:40 - 16:05 | Scaling Quality in High-Volume Diagnostics Networks Enabling Precision at Scale | Dr. Shakti Aggarwal

16:05 - 16:30 | The Art of Scale: Mastering Laboratory Management at 20000+ Tests per Day | Prof. Etem Özkaya

This session explores transformative advances in laboratory medicine, highlighting automation’s role in enhancing efficiency, quality, and patient care. Experts address clinical nuances in serum oncomarkers, primary aldosteronism, congenital adrenal hyperplasia, and celiac disease diagnostics. Innovations in diagnostic systems (Snibe) and total laboratory automation (TLA) implementation are showcased alongside case-based insights. Sessions emphasizes scaling quality in high-volume networks and mastering large-scale lab operations exceeding 20,000 tests daily. Discussions span cardiovascular and endocrine disorders, underlining the critical link between cutting-edge technology and precision diagnostics in modern healthcare.

Learning objectives

• Understand how automation enhances laboratory efficiency, quality, and patient outcomes.
• Evaluate clinical benefits and limitations of serum oncomarker testing.
• Identify challenges and best practices in diagnosing primary aldosteronism and congenital adrenal hyperplasia.
• Recognize the value of integrated diagnostic platforms like Snibe TLA in clinical workflows.
• Learn strategies for scaling quality and managing high-throughput laboratory

 11 February 2026

 11:00 am - 1:00 pm

 Hosted by

Overview

Discover how MGI’s open, ecosystem-driven approach is redefining next-generation multi-omics laboratories. This workshop will showcase how MGI’s new T1+ platform, together with its All-in-One (AIO) and PrepAll integrated solutions, enables fully automated, end-to-end workflows- from library preparation through sequencing readiness and data enablement. Featuring seamless integration with trusted third-party kits and real-world customer perspectives, the session will demonstrate how open-platform ecosystems reduce operational complexity, improve efficiency, and confidently scale multi-omics applications across clinical, translational, and population-level research.

Learning objectives

• Understand how an open, ecosystem-driven platform strategy enables flexible, interoperable, and future-ready multi-omics laboratories, reducing dependency on single-vendor workflows while supporting evolving scientific and clinical demands.
• Learn how integrated, end-to-end automation platforms enable seamless multi-omics workflows, spanning sample and library preparation, sequencing readiness, and data enablement within a unified operational framework.
• Evaluate the operational and efficiency gains achieved through integrated automation, including reduced hands-on time, improved reproducibility, and simplified laboratory workflows.
• Explore how seamless integration with trusted third-party kits expands application breadth, supporting clinical, translational, and population-scale multi-omics research.
• Gain real-world insights from customer implementations on how open-platform ecosystems help laboratories scale confidently while managing complexity, throughput, and long-term growth.

 11 February 2026

 2:00 - 3:00 pm

 Hosted by

Overview

Workshop showcasing the impact of AI in cervical cancer screening, demonstrating how it can improve efficiency and workflow in the cytopathology lab, and featuring real customer experiences with implementing AI-driven digital cytology for cervical screening.

Learning objectives

• Role of AI in cervical cancer diagnosis
• Impact of AI on efficiency and workflow in cytopathology
• Real-world customer case on AI implementation
• Update on the latest AI-powered digital cytology innovations for cervical cancer

 12 February 2026

 11:00 am - 1:00 pm

 Hosted by

Overview

11:00 - 11:40 | Clinical Impact of Molecular Diagnostics in Modern Healthcare
Explores how molecular diagnostics drive accurate diagnosis, informed treatment decisions, and improved patient outcomes, with a focus on test selection, result interpretation, quality practices, and effective clinician–laboratory collaboration.

Learning objectives:
» Understand the clinical value and applications of molecular diagnostics in patient care

» Interpret molecular test results accurately while recognizing key diagnostic risks

» Strengthen laboratory–clinician collaboration to support safe, evidence-based decisions

11:40 - 12:20 | Finance for Non-Finance Professionals.
A practical introduction to essential financial principles, helping non-finance professionals confidently interpret financial information and understand its impact on organizational performance and decision-making.

Learning objectives:
» Understand core financial statements and key performance indicators

» Interpret financial data to assess performance, liquidity, and cash flow

» Apply practical budgeting principles to support informed decision-making

12:20 - 13:00 | Laboratory Consolidation Operational Optimization
Examines best practices for consolidating laboratory services into a unified, high-performing model, covering workflow harmonization, resource optimization, LIS integration, and data-driven KPIs to improve efficiency without compromising quality or turnaround times.

Learning objectives:
» Understand the principles and benefits of laboratory consolidation

» Apply harmonization and data-driven strategies to optimize operations

» Improve efficiency, quality, and sustainability across consolidated laboratory services

 12 February 2026

 2:00 - 3:45 pm

 Hosted by

Overview

Discover how advances in laboratory diagnostics and health system reform are shaping contemporary approaches to the diagnosis and care of haematological malignancies in this three-part educational session.

Explore the use of advanced haematology analyser white pathological and precursor blood cell application 'WPC' to support earlier identification of haematological malignancies and optimise laboratory workflows. Learn about the evolving clinical role of multiparametric flow cytometry in diagnosis, classification, and monitoring, including immunophenotyping strategies and measurable residual disease (MRD) assessment. Gain a real-world perspective on haemato-oncology care, examining how national health system reforms and universal health insurance can facilitate equitable access to advanced diagnostics and sustainable care pathways, informed by Egypt’s nationwide transformation.

Join us for an insightful session highlighting how laboratory innovation and system-level change together can improve diagnostic accuracy and patient care.

Learning objectives

• Identify haematology analyser parameters for early detection of haematological malignancies.
• Explain the use of flow cytometry in haematological malignancies.
• Recognise immunophenotyping and MRD assessment in disease evaluation.
• Understand how combined diagnostic approaches improve patient care.
• Understand how health system reforms and universal health insurance support equitable haemato-oncology care